Altra Pharma-Chem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-07-2024
- Paid Up Capital ₹ 0.48 M
as on 16-07-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 82.50 M
as on 16-07-2024
- Satisfied Charges ₹ 35.65 M
as on 16-07-2024
- Revenue 93.58%
(FY 2022)
- Profit 211.77%
(FY 2022)
- Ebitda 132.88%
(FY 2022)
- Net Worth 68.26%
(FY 2022)
- Total Assets 35.93%
(FY 2022)
About Altra Pharma-Chem
The Corporate was formerly known as Roltex Rubber Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.48 M.
The company currently has active open charges totaling ₹8.25 Cr. The company has closed loans amounting to ₹3.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Banubai Patil, Mithun Patil, and Prachi Patil serve as directors at the Company.
- CIN/LLPIN
U24100MH1995PTC087600
- Company No.
087600
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Altra Pharma-Chem?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Banubai Patil | Director | 19-Aug-2011 | Current |
Mithun Patil | Director | 19-Aug-2011 | Current |
Prachi Patil | Director | 07-Mar-2013 | Current |
Financial Performance and Corporate Structure Insights of Altra Pharma-Chem.
Altra Pharma-Chem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.58% increase. The company also saw a substantial improvement in profitability, with a 211.77% increase in profit. The company's net worth Soared by an impressive increase of 68.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Altra Pharma-Chem?
In 2023, Altra Pharma-Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Altra Organics & Chemicals Private Limited
Active 15 years 11 monthsBanubai Patil and Mithun Patil are mutual person
Altra Agro-Chem Private Limited
Active 5 years 4 monthsMithun Patil and Prachi Patil are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 25 Nov 2022 | ₹5.75 Cr | Open |
Others Creation Date: 13 Jul 2013 | ₹2.50 Cr | Open |
Others Creation Date: 28 Jan 2012 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Altra Pharma-Chem?
Unlock and access historical data on people associated with Altra Pharma-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Altra Pharma-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altra Pharma-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.